Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $4.3800 (6.7%) ($4.3800 - $4.3800) on Fri. Jun. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.61% (three month average) | RSI | 27 | Latest Price | $4.3800(6.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -3.1% a day on average for past five trading days. | Weekly Trend | TGTX declines -17.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(70%) IBB(65%) ARKK(61%) IBUY(52%) | Factors Impacting TGTX price | TGTX will decline at least -3.305% in a week (0% probabilities). VIXM(-49%) VXX(-48%) TBT(-28%) UUP(-21%) USO(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.305% (StdDev 6.61%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-23.2(-629.68%) | Resistance Level | $5.52 | 5 Day Moving Average | $4.4(-0.45%) | 10 Day Moving Average | $4.75(-7.79%) | 20 Day Moving Average | $5.52(-20.65%) | To recent high | -58.4% | To recent low | 11.9% | Market Cap | $555m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |